Literature DB >> 9651215

Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol.

G C Chan1, T R Hinds, S Impey, D R Storm.   

Abstract

Marijuana consumption elicits diverse physiological and psychological effects in humans, including memory loss. Here we report that Delta9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is toxic for hippocampal neurons. Treatment of cultured neurons or hippocampal slices with THC caused shrinkage of neuronal cell bodies and nuclei as well as genomic DNA strand breaks, hallmarks of neuronal apoptosis. Neuron death induced by THC was inhibited by nonsteroidal anti-inflammatory drugs, including indomethacin and aspirin, as well as vitamin E and other antioxidants. Furthermore, treatment of neurons with THC stimulated a significant increase in the release of arachidonic acid. We hypothesize that THC neurotoxicity is attributable to activation of the prostanoid synthesis pathway and generation of free radicals by cyclooxygenase. These data suggest that some of the memory deficits caused by cannabinoids may be caused by THC neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651215      PMCID: PMC6793471     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

1.  Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death.

Authors:  R S Morrison; H J Wenzel; Y Kinoshita; C A Robbins; L A Donehower; P A Schwartzkroin
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

2.  Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1.

Authors:  Q Chen; M Galleano; A I Cederbaum
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

3.  Short-term memory impairment in cannabis-dependent adolescents.

Authors:  R H Schwartz; P J Gruenewald; M Klitzner; P Fedio
Journal:  Am J Dis Child       Date:  1989-10

Review 4.  Neurobiology of marijuana abuse.

Authors:  M E Abood; B R Martin
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

5.  NMDA-dependent superoxide production and neurotoxicity.

Authors:  M Lafon-Cazal; S Pietri; M Culcasi; J Bockaert
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

Review 6.  Health aspects of cannabis.

Authors:  L E Hollister
Journal:  Pharmacol Rev       Date:  1986-03       Impact factor: 25.468

7.  Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats.

Authors:  A Stiglick; H Kalant
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice.

Authors:  D R Collins; R G Pertwee; S N Davies
Journal:  Eur J Pharmacol       Date:  1994-07-11       Impact factor: 4.432

9.  Neuroprotective action of cycloheximide involves induction of bcl-2 and antioxidant pathways.

Authors:  K Furukawa; S Estus; W Fu; R J Mark; M P Mattson
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  54 in total

1.  Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users.

Authors:  Joseph P Schacht; Kent E Hutchison; Francesca M Filbey
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 2.  Neurons on cannabinoids: dead or alive?

Authors:  Manuel Guzman
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

3.  Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry.

Authors:  Krista Lisdahl Medina; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert
Journal:  Neurotoxicol Teratol       Date:  2006-12-12       Impact factor: 3.763

4.  Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence.

Authors:  Krista Lisdahl Medina; Karen L Hanson; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert
Journal:  J Int Neuropsychol Soc       Date:  2007-09       Impact factor: 2.892

5.  Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.

Authors:  Igor Grant; B Rael Cahn
Journal:  Clin Neurosci Res       Date:  2005

6.  The basal level of intracellular calcium gates the activation of phosphoinositide 3-kinase-Akt signaling by brain-derived neurotrophic factor in cortical neurons.

Authors:  Fei Zheng; Deborah Soellner; Joseph Nunez; Hongbing Wang
Journal:  J Neurochem       Date:  2008-05-12       Impact factor: 5.372

Review 7.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 8.  Generation of Febrile Seizures and Subsequent Epileptogenesis.

Authors:  Bo Feng; Zhong Chen
Journal:  Neurosci Bull       Date:  2016-08-25       Impact factor: 5.203

Review 9.  Signal transduction via cannabinoid receptors.

Authors:  George D Dalton; Caroline E Bass; C G Van Horn; Allyn C Howlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

10.  A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis.

Authors:  Rosanna Cozzolino; Gaetano Calì; Maurizio Bifulco; Paolo Laccetti
Journal:  Invest New Drugs       Date:  2009-02-03       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.